DE60305063D1 - Ccr1-rezeptor-antagonisten zur behandlung u.a. demyelinisierender entzündlicher erkrankungen - Google Patents

Ccr1-rezeptor-antagonisten zur behandlung u.a. demyelinisierender entzündlicher erkrankungen

Info

Publication number
DE60305063D1
DE60305063D1 DE60305063T DE60305063T DE60305063D1 DE 60305063 D1 DE60305063 D1 DE 60305063D1 DE 60305063 T DE60305063 T DE 60305063T DE 60305063 T DE60305063 T DE 60305063T DE 60305063 D1 DE60305063 D1 DE 60305063D1
Authority
DE
Germany
Prior art keywords
demyelinising
treatment
receptor antagonists
inflammatory diseases
ccr1 receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60305063T
Other languages
English (en)
Other versions
DE60305063T2 (de
Inventor
G Carson
C Harriman
Shomir Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of DE60305063D1 publication Critical patent/DE60305063D1/de
Application granted granted Critical
Publication of DE60305063T2 publication Critical patent/DE60305063T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
DE2003605063 2002-11-13 2003-11-12 Ccr1-rezeptor-antagonisten zur behandlung von u.a. demyelinisierenden entzündlichen erkrankungen Expired - Lifetime DE60305063T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42594702P 2002-11-13 2002-11-13
US425947P 2002-11-13
PCT/US2003/035817 WO2004043965A1 (en) 2002-11-13 2003-11-12 Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease

Publications (2)

Publication Number Publication Date
DE60305063D1 true DE60305063D1 (de) 2006-06-08
DE60305063T2 DE60305063T2 (de) 2006-11-16

Family

ID=32313083

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60332663T Expired - Lifetime DE60332663D1 (de) 2002-11-13 2003-11-12 CCR1-Rezeptor-Antagonisten zur Behandlung u.a. Demyelinisierender entzündlicher Erkrankungen
DE2003605063 Expired - Lifetime DE60305063T2 (de) 2002-11-13 2003-11-12 Ccr1-rezeptor-antagonisten zur behandlung von u.a. demyelinisierenden entzündlichen erkrankungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60332663T Expired - Lifetime DE60332663D1 (de) 2002-11-13 2003-11-12 CCR1-Rezeptor-Antagonisten zur Behandlung u.a. Demyelinisierender entzündlicher Erkrankungen

Country Status (25)

Country Link
US (7) US20040106639A1 (de)
EP (2) EP1669356B1 (de)
JP (1) JP4644491B2 (de)
KR (1) KR101109348B1 (de)
CN (1) CN100343257C (de)
AR (1) AR041942A1 (de)
AT (2) ATE468340T1 (de)
AU (2) AU2003291452A1 (de)
BR (1) BR0316261A (de)
CA (1) CA2505874C (de)
CY (1) CY1107985T1 (de)
DE (2) DE60332663D1 (de)
DK (1) DK1562954T3 (de)
EA (1) EA007748B1 (de)
ES (2) ES2346337T3 (de)
HK (2) HK1074046A1 (de)
IL (2) IL168384A (de)
MX (1) MXPA05005105A (de)
NO (1) NO331855B1 (de)
PL (1) PL211022B1 (de)
PT (1) PT1562954E (de)
SI (1) SI1562954T1 (de)
TW (1) TWI291467B (de)
WO (1) WO2004043965A1 (de)
ZA (2) ZA200504144B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) * 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
EP1841429B1 (de) 2004-12-17 2012-04-18 Millennium Pharmaceuticals, Inc. Solide formen eines chemokin-rezeptorantagonisten und anwendungsverfahren dafür
DK1828160T3 (da) 2004-12-21 2012-02-13 Merck Serono Sa Cykliske sulfonylaminoderivater og anvendelse deraf som MMP-hæmmere
UA86862C2 (en) 2005-01-31 2009-05-25 Лаборатуар Сероно С.А. N-hydroxyamide derivatives and use thereof
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
BRPI0616118A2 (pt) 2005-09-01 2011-06-07 Ares Trading Sa tratamento de neurite ótica
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
KR20090020694A (ko) * 2006-07-14 2009-02-26 일라이 릴리 앤드 캄파니 글루코코르티코이드 수용체 조절제 및 이의 사용 방법
US8501782B2 (en) 2007-07-24 2013-08-06 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
US8288371B2 (en) * 2007-10-05 2012-10-16 Pharmacopeia, Llc Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
EP2231675A1 (de) * 2007-11-30 2010-09-29 Millennium Pharmaceuticals, Inc. Verfahren zur herstellung von 5-cyclopropyl-5,11-dihydro(1)benzoxepino(3,4-b)pyridin-5-ol unter verwendung von tmeda
US20090286823A1 (en) * 2007-12-17 2009-11-19 Millennium Pharmaceuticals Inc. CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders
JP2011525474A (ja) 2008-01-11 2011-09-22 イーライ リリー アンド カンパニー リウマチの治療のための糖質コルチコイド受容体調節因子としての（Ｅ）−Ｎ−｛３−［１−（８−フルオロ−１１Ｈ−１０−オキサ−１−アザ−ジベンゾ［ａ，ｄ］シクロヘプテン−５−イリデン）プロピル］フェニル｝メタンスルホンアミド
TWI433838B (zh) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 作為趨化因子受體活性調節劑之六氫吡啶衍生物
EP2771484A1 (de) 2011-10-28 2014-09-03 Galderma Research & Development Neue leukozyteninfiltratmarker für rosacea und verwendungen davon

Family Cites Families (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD80449A (de)
DE80449C (de)
US377729A (en) * 1888-02-07 Half to phillips
GB1003292A (en) 1960-12-08 1965-09-02 Sandoz Ag Improvements in or relating to 4-azathiaxanthene derivatives
FR1332145A (de) 1961-06-08 1963-12-16
CH416624A (de) 1962-10-23 1966-07-15 Sandoz Ag Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
NL132137C (de) * 1963-04-24
FR88751E (de) 1963-07-09 1967-06-07
GB1085405A (en) 1963-10-14 1967-10-04 Pfizer & Co C Dibenzoxepins and dibenzthiepins
FR145F (de) 1964-06-01
CH421138A (de) 1965-11-04 1966-09-30 Wander Ag Dr A Verfahren zur Herstellung von Thioxanthenderivaten
US3409621A (en) * 1966-04-01 1968-11-05 Schering Corp Piperazino-aza-dibenzo-[a, d]-cycloheptenes
US3625974A (en) 1967-04-28 1971-12-07 Fujisawa Pharmaceutical Co Dibenzothiazepine derivatives
GB1206216A (en) 1967-07-18 1970-09-23 Pfizer & Co C Aminopropylidene dibenzoxepine tranquilizers
NL6905642A (de) 1968-04-12 1969-10-14
JPS4830064B1 (de) 1968-12-23 1973-09-17
JPS4840356Y1 (de) 1969-12-22 1973-11-27
US3770729A (en) * 1970-12-22 1973-11-06 Yoshitomi Pharmaceutical N substituted piperidine compounds
GB1330966A (en) 1970-12-22 1973-09-19 Yoshitomi Pharmaceutical N-substituted piperidine compounds methods for their production and pharmaceutical compositions containing them
JPS5146625Y2 (de) 1971-03-24 1976-11-10
GB1323659A (en) 1971-04-10 1973-07-18 Yoshitomi Pharmaceutical Piperazine derivatives methods for their production and pharmaceuticl compositions containing them
CA1010870A (en) * 1972-12-08 1977-05-24 Niels Lassen Thiaxanthene derivative and method
US4250176A (en) * 1976-12-21 1981-02-10 Janssen Pharmaceutica N.V. Piperazine derivatives
US4335122A (en) * 1981-03-18 1982-06-15 Hoechst-Roussel Pharmaceuticals Inc. Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use
DE3326641A1 (de) 1982-07-27 1984-02-02 Basf Ag, 6700 Ludwigshafen 5,6-dihydro-11-h-morphantridin-6-one, ihre herstellung und diese enthaltende arzneimittel
CA1237428A (en) * 1983-06-24 1988-05-31 Hiroshi Tanaka ¬1| benzepino¬3,4-b|pyridine derivative
ES524680A0 (es) 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
DE3402060A1 (de) * 1984-01-21 1985-08-01 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CS236550B1 (cs) 1984-02-02 1985-05-15 Miroslav Protiva Způsob přípravy esterů piperazinoalkanolů dibenzo(b,e)thiepinové řady a jejich solí s kyselinou maleinovou
CS236549B1 (cs) 1984-02-02 1985-05-15 Miroslav Protiva Piperazinoalkanoly dibenzo(b,e)thiepinové řady a jejich soli s kyselinou maleinovou
CS240698B1 (cs) 1984-10-12 1986-02-13 Miroslav Protiva Substituované ll-(piperidinoalkyl)-6,ll-dihydrodibenzo (b,e)thiepin-ll-karbonitrily
JPH0665664B2 (ja) 1985-01-18 1994-08-24 大塚製薬株式会社 モルフアントリジン誘導体
SE8500273D0 (sv) * 1985-01-22 1985-01-22 Leo Ab Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
WO1988000049A1 (en) 1986-06-26 1988-01-14 Kyowa Hakko Kogyo Co., Ltd. Antiarrhythmic agent
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IT8721978A0 (it) 1987-09-21 1987-09-21 Angeli Inst Spa Nuovi derivati ammidinici triciclici.
US4882351A (en) * 1987-10-14 1989-11-21 Roussel Uclaf Tricyclic compounds
US4994463A (en) * 1987-12-14 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Tricyclic thromboxane A2 antagonists
ATE108453T1 (de) 1988-04-28 1994-07-15 Schering Corp Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung.
US5242931A (en) * 1988-06-09 1993-09-07 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds as TXA2 antagonists
CA1338625C (en) * 1988-06-09 1996-10-01 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
DE3827093A1 (de) 1988-08-10 1990-02-15 Nattermann A & Cie Verfahren zur herstellung von hochreinem ebselen
DE3838912A1 (de) * 1988-11-17 1990-05-23 Thomae Gmbh Dr K Mittel zur behandlung von akuten und chronischen obstruktiven atemwegserkrankungen
JPH0694464B2 (ja) * 1991-01-23 1994-11-24 協和醗酵工業株式会社 三環式化合物およびその中間体
CA2062587A1 (en) * 1991-03-11 1992-09-12 Toshiaki Kumazawa Indole derivatives
WO1992016226A1 (en) 1991-03-19 1992-10-01 Smithkline Beecham Corporation Il-1 inhibitors
EP0515158A1 (de) 1991-05-23 1992-11-25 Schering Corporation Benzopyridopiperidyliden-Verbindungen, Zusammensetzungen, Methoden zur Herstellung und Verwendung
AU2392392A (en) 1991-07-23 1993-02-23 Schering Corporation Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use
US5378701A (en) * 1991-12-27 1995-01-03 Kyowa Hakko Kogyo Tricyclic compounds
US5679703A (en) * 1992-09-16 1997-10-21 Kyowa Hakko Kogyo, Co., Ltd. Tricyclic compounds having ACAT inhibiting activity
JP3664176B2 (ja) 1992-11-10 2005-06-22 ジェネンテック・インコーポレーテッド Ｃ−ｃ ｃｋｒ−１，ｃ−ｃケモカインレセプター
US5538986A (en) * 1993-12-06 1996-07-23 Schering Corporation Tricyclic derivatives, compositions and methods of use
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
WO1996031469A1 (en) 1995-04-07 1996-10-10 Novo Nordisk A/S N-substituted azaheterocyclic carboxylic acids and esters thereof
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
AU5271096A (en) 1995-04-07 1996-10-23 Novo Nordisk A/S Novel heterocyclic compounds
UA54385C2 (uk) * 1995-04-07 2003-03-17 Ново Нордіск А/С N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
JPH0940662A (ja) 1995-05-24 1997-02-10 Kyowa Hakko Kogyo Co Ltd 三環式化合物
CA2231773A1 (en) * 1995-09-13 1997-03-20 Shigeru Aono Phenylpiperidine derivative
WO1997024325A1 (en) 1995-12-28 1997-07-10 Takeda Chemical Industries, Ltd. DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
DE29602088U1 (de) 1996-02-07 1996-04-04 Buemach Engineering Internatio Verschraubbarer druckmittelbetätigter Arbeitszylinder mit Verschlußteilen zur Kopplung des Zylinderrohres
WO1997044329A1 (en) 1996-05-20 1997-11-27 Teijin Limited Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
US6281212B1 (en) * 1996-07-12 2001-08-28 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EP0916668A4 (de) 1996-07-29 2000-08-16 Banyu Pharma Co Ltd Chemokin-rezeptor-antagonisten
CN1104427C (zh) 1996-09-13 2003-04-02 先灵公司 法呢基蛋白转移酶的三环抑制剂
ID22156A (id) 1996-09-13 1999-09-09 Schering Corp Turunan substitusi benzosikloheptapiridina yang berguna untuk menghambat fernesil protein transferase
CA2264666A1 (en) 1996-09-13 1998-03-19 Schering Corporation Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
EP0931078B1 (de) 1996-09-13 2006-11-15 Schering Corporation Tricyclische piperdinyl derivate verwendbar als farnesyl-protein transferase inhibitoren
WO1998011106A1 (en) 1996-09-13 1998-03-19 Schering Corporation Tricyclic compounds useful as fpt inhibitors
NZ334340A (en) 1996-09-13 2000-09-29 Schering Corp Tricyclic compounds that inhibits farnesyl protein transferase I but not geranylgeranyl protein transferase I in the treatment of cancer or cancer-like conditions
ES2229340T3 (es) 1996-09-13 2005-04-16 Schering Corporation Compuestos triciclicos antitumorales, inhibidores de farnesil-proteina-tranferasa.
ZA978792B (en) 1996-10-04 1998-04-06 Novo Nordisk As N-substituted azaheterocyclic compounds.
DK0934312T3 (da) 1996-10-04 2003-07-21 Novo Nordisk As 1,4-disubstituerede piperaziner
HUP0000088A3 (en) 1996-10-04 2000-09-28 Novo Nordisk As N-substituted azaheterocyclic compounds, process for producing them and pharmaceutical compositions containing them
AU5604998A (en) 1996-12-13 1998-07-03 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5522498A (en) 1996-12-13 1998-07-03 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
WO1998025605A1 (en) 1996-12-13 1998-06-18 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5812498A (en) 1996-12-20 1998-07-17 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
WO1998043638A1 (fr) 1997-03-27 1998-10-08 Kyowa Hakko Kogyo Co., Ltd. Agent therapeutique pour maladies auto-immunes
US5877177A (en) * 1997-06-17 1999-03-02 Schering Corporation Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6040318A (en) 1997-06-25 2000-03-21 Novo Nordisk A/S Tricycle substituted with azaheterocyclic carboxylic acids
JP2002515914A (ja) 1997-06-25 2002-05-28 ノボ ノルディスク アクティーゼルスカブ 新規へテロ環式化合物
US6048856A (en) * 1997-12-17 2000-04-11 Novo Nordisk A/S Heterocyclic compounds
US6433165B1 (en) * 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
DE69928226T8 (de) * 1998-01-21 2006-10-19 Millennium Pharmaceuticals, Inc., Cambridge Chemokin rezeptor antagonisten und verwendung
US6509346B2 (en) * 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) * 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) * 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) * 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US20020169155A1 (en) * 1998-09-04 2002-11-14 Millennium Pharmaceuticals, Inc. Chemokine receptor anagonists and methods of use therefor
EP1109815A1 (de) 1998-09-04 2001-06-27 Millennium Pharmaceuticals, Inc. Chemokin-rezeptor-antagonisten und verwendung
MXPA04004826A (es) 1998-09-04 2004-08-11 Millenium Pharmaceuticals Inc Antagonista del receptor de quimioquinas y metodos para su uso.
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
WO2000032193A1 (en) 1998-12-02 2000-06-08 Novo Nordisk A/S Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis
AU6503900A (en) * 1999-07-28 2001-02-19 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
AU6499100A (en) 1999-07-28 2001-02-19 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
JP4889920B2 (ja) * 2001-11-21 2012-03-07 ミレニアム ファーマシューティカルズ， インコーポレイテッド ケモカイン受容体アンタゴニストおよびその使用方法
TWI291467B (en) * 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
US7639107B2 (en) 2005-04-20 2009-12-29 Mitsubishi Denki Kabushiki Kaisha Overcurrent relay
JP4715952B2 (ja) 2009-02-18 2011-07-06 村田機械株式会社 フロッグレッグ型移載装置

Also Published As

Publication number Publication date
AU2003291452A1 (en) 2004-06-03
US20100249174A1 (en) 2010-09-30
EA007748B1 (ru) 2006-12-29
DK1562954T3 (da) 2006-08-28
CN1738824A (zh) 2006-02-22
EP1562954B1 (de) 2006-05-03
TWI291467B (en) 2007-12-21
EA200500803A1 (ru) 2005-10-27
CY1107985T1 (el) 2013-09-04
US20080139602A1 (en) 2008-06-12
IL210046A (en) 2015-07-30
WO2004043965A1 (en) 2004-05-27
MXPA05005105A (es) 2005-07-01
NO20052272L (no) 2005-06-06
ATE325124T1 (de) 2006-06-15
ZA200504144B (en) 2007-04-25
KR101109348B1 (ko) 2012-01-31
CN100343257C (zh) 2007-10-17
BR0316261A (pt) 2005-10-11
US20130289063A1 (en) 2013-10-31
US20040106639A1 (en) 2004-06-03
PL377715A1 (pl) 2006-02-06
AU2008202965A1 (en) 2008-07-31
US8394817B2 (en) 2013-03-12
SI1562954T1 (sl) 2006-10-31
NO331855B1 (no) 2012-04-23
US7732459B2 (en) 2010-06-08
DE60305063T2 (de) 2006-11-16
US7977350B2 (en) 2011-07-12
IL168384A (en) 2011-01-31
US20050288319A1 (en) 2005-12-29
HK1074046A1 (en) 2005-10-28
PL211022B1 (pl) 2012-03-30
US9334283B2 (en) 2016-05-10
IL210046A0 (en) 2011-07-31
ATE468340T1 (de) 2010-06-15
EP1669356A1 (de) 2006-06-14
PT1562954E (pt) 2006-07-31
CA2505874A1 (en) 2004-05-27
KR20050074609A (ko) 2005-07-18
EP1562954A1 (de) 2005-08-17
EP1669356B1 (de) 2010-05-19
US20110230516A1 (en) 2011-09-22
ZA200607868B (en) 2008-01-08
JP2006508966A (ja) 2006-03-16
CA2505874C (en) 2012-07-17
DE60332663D1 (de) 2010-07-01
JP4644491B2 (ja) 2011-03-02
US20150005338A1 (en) 2015-01-01
AU2008202965B2 (en) 2012-03-22
ES2346337T3 (es) 2010-10-14
HK1086011A1 (en) 2006-09-08
ES2261979T3 (es) 2006-11-16
TW200413347A (en) 2004-08-01
AR041942A1 (es) 2005-06-01

Similar Documents

Publication Publication Date Title
DE60305063D1 (de) Ccr1-rezeptor-antagonisten zur behandlung u.a. demyelinisierender entzündlicher erkrankungen
EP1556047A4 (de) Pgd2-rezeptor-antagonisten zur behandlungvon entz ndlichen erkrankungen
ATE424386T1 (de) Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
IL178328A0 (en) Pgd2 receptor antagonists for the treatment of inflammatory diseases
MX2007000036A (es) Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias.
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
IL164263A0 (en) Use of ep4 receptor ligands on the treatment of il-6 involved diseases
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
BR0304291B1 (pt) absorvente higiÊnico.
NO20052914D0 (no) Terapeutiske forbindelser
DK1556342T3 (da) Phenethanolaminderivat til behandling af respiratoriske sygdomme
DE60324099D1 (de) Arzneistoffhaltiger tampon
DK1862458T3 (da) Terapeutiske midler anvendelige til smertebehandling
DE60308767D1 (de) Anti-Rückwärts Vorrichtung
DE602004014547D1 (de) Funduskamera
DE60332134D1 (de) Gerät zwecks hämodynamischbasierter optimierung der kardialen stimulation
ATE469875T1 (de) Nk1-antagonisten
NO20044188L (no) Kontrollerte frigjoringsdoseformer
DE60315490D1 (de) Therapeutische behandlung
FR2837224B1 (fr) Bonde traitante
DE60331041D1 (de) Orale dosierform für die kontrollierte arzneimittelfreisetzung
DE602004021568D1 (de) Thiadibenzoazulenderivate zur behandlung von entzündlichen erkrankungen
NO20030716D0 (no) Stimulator for vagina
ITMI20031273A1 (it) Composizioni a base di cenere di vegetali per la terapia di affezioni cutanee.
NO20025959D0 (no) Dispenser for tanntråd

Legal Events

Date Code Title Description
8364 No opposition during term of opposition